Stubborn liver cancer may have met its match in century-old TB vaccine
A single injection of the 102-year-old tuberculosis vaccine, BCG, has proven effective at triggering an immune response in mice and shrank their liver cancer tumors, according to research by UC Davis Health. The findings suggest that BCG might be an alternative way of treating this notoriously hard-to-treat cancer.As the most common type of liver cancer, hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide. Despite treatment options that include surgery, radio- and chemotherapy,…